期刊文献+

尿毒症患者多形核白细胞糖皮质激素受体与趋化移动的改变及意义

Changes of Glucocorticoid Receptor and Chemotactic Migration of Polymorphonuclear Leukocytes in Patients with Uremia
暂未订购
导出
摘要 应用放射配体结合分析,检测尿毒症患者外周血多形核白细胞(PML)的糖皮质激素受体(GR),尿毒症患者PMLGR的最大结合容量(Bmax)明显低于对照组,而其解离常数(Kd)比对照组的显著升高。同时检测GR的效应指标:皮质醇(F)对PML的趋化移动(ChtM)的抑制率(FI),F对ChtM的FI明显低于对照组,与降低的GR呈正相关(r=0.785,P<0.01).尿毒症患者PML的GR降低的同时,伴效应指标的改变,表明GR的降低具有临床意义。尿毒症患者PML的随机移动(RM)和ChtM均明显降低,提示白细胞功能降低。 Glucocorticoid receptor (GR) of human peripheral polymorphonuclear leukocytes (PML)from thirty patients with uremia were investigated with[3H]dexamethasone as radioligand to determine the maximal binding capacity (Bmax) and dissociation constant (Kd) of GR, which were 3508±598 site/cell and 11. 7±2.6nmol/L, respectively and were significantly different from those of the controls (7250±1006site/cell, P<0.01 and 5.3±1.9nmol/L, P<0.05, respectively). Random migration (RM) and chemotactic migration (ChtM) of PML in uremic patients were significantly decreased as compared with those of the healthy subjects. The fraction inhibition (FI) of ChtM by hydrocortisone was lower in patients than in the normal persons and was positively correlated with the lowered Bmax of GR on PML(r=0. 785,P<0.01), indicating that the reduced GR binding sites on PML of uremic patients were accompanied by the lowered migratory function of PML,i. e. the effector parameter and may have implication in the development of the disease.
出处 《标记免疫分析与临床》 CAS 1995年第3期125-128,共4页 Labeled Immunoassays and Clinical Medicine
关键词 尿毒症 受体 糖皮质激素 趋化性 多形核白细胞 Uremia Neutrophils Receptors glucocorticoid Hydrocortisone Chemotaxis
  • 相关文献

参考文献4

二级参考文献5

  • 1田英,中国病理生理杂志,1986年,2卷,1期,15页
  • 2张家庆,国外医学内科学分册,1985年,11卷,3期,107页
  • 3田英,中华核医学杂志,1983年,3期,27页
  • 4徐仁宝,生理科学进展,1980年,11卷,1期,19页
  • 5田英,中华核医学杂志,1983年,3期,27页

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部